MEDIWOUND LTD. Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019
MEDIWOUND LTD. (MDWD) had Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 of $15.36 per share as of 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 · last filed 2026-03-05
- 2025-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 $15.36.
- 2024-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 $16.67.
- 2023-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 $19.34.
- 2022-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 $30.44.
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 as first filed |
|---|---|---|
| 2025-12-31 | $15.36 20-F · filed 2026-03-05 | |
| 2024-12-31 | $16.67 20-F · filed 2026-03-05 | |
| 2023-12-31 | $19.34 20-F · filed 2026-03-05 | |
| 2022-12-31 | $30.44 20-F · filed 2026-03-05 | |
| 2021-12-31 | $44.45 20-F · filed 2025-03-19 | $6.35 20-F · filed 2022-03-17 |
| 2020-12-31 | $45.85 20-F · filed 2024-03-21 | $6.55 20-F · filed 2021-02-25 |
| 2019-12-31 | $64.26 20-F · filed 2023-03-16 | $9.18 20-F · filed 2020-02-25 |
| 2018-12-31 | $9.31 20-F · filed 2022-03-17 | |
| 2017-12-31 | $10.02 20-F · filed 2021-02-25 | |
| 2016-12-31 | $9.62 20-F · filed 2020-02-25 |